EMROSI
LIVE

Serial Number

98834968

Owner

Journey Medical Corporation

Attorney

Brendan J. Hughes

First Use Date

Mar 17, 2025

Filing Date

Nov 4, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EMROSI Trademark

Serial Number: 98834968 • Registration: 8225818

EMROSI is a trademark filed by Journey Medical Corporation on November 4, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Journey Medical Corporation

Scottsdale, AZ 85258

Entity Type: 03

Trademark Details

Filing Date

November 4, 2024

Registration Date

April 21, 2026

First Use Anywhere

March 17, 2025

First Use in Commerce

March 17, 2025

Published for Opposition

July 8, 2025

Goods & Services

Medicated skin preparation for the treatment of rosacea; Medicated skin preparation for the treatment of erythema

Providing medical information in the field of skin conditions

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 21, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 2, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 2, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 4, 2026 SUPC
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 20, 2025 EXRA
USE AMENDMENT FILED
Sep 19, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 19, 2025 EISU
SOU EXTENSION 1 GRANTED
Sep 19, 2025 EX1G
SOU EXTENSION 1 FILED
Sep 19, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 19, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 2, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 8, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 8, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 2, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 13, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 29, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2025 CRFA
ASSIGNED TO LIE
May 29, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 15, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 2, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
May 2, 2025 GNSL
SUSPENSION LETTER WRITTEN
May 2, 2025 CNSL
ASSIGNED TO EXAMINER
May 2, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
NEW APPLICATION ENTERED
Nov 4, 2024 NWAP